Versant Venture Management as of March 31, 2015
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 6 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Clovis Oncology | 53.2 | $61M | 815k | 74.23 | |
| Five Prime Therapeutics | 21.9 | $25M | 1.1M | 22.85 | |
| Achaogen | 11.0 | $13M | 1.3M | 9.76 | |
| Cymabay Therapeutics | 6.4 | $7.3M | 1.0M | 6.92 | |
| Inogen (INGN) | 4.4 | $5.0M | 155k | 31.99 | |
| Kythera Biopharmaceuticals I | 3.1 | $3.5M | 70k | 50.15 |
